Table 2. Clinical and pathological characteristics of 80 pasteur hospital patients with advanced-stage NSCLC included in this study.
| Patients demographics (n = 80) | N (%) |
|---|---|
| Age (years) | |
| Median (range) | 65 (41–86) |
| Sex | |
| Male | 54 (68%) |
| Female | 26 (32%) |
| Tobacco Use History | |
| Former or current smokers | 67 (84%) |
| Never smoked | 13 (16%) |
| Histological cell type | |
| Invasive adenocarcinoma | 63 (79%) |
| Squamous cell carcinoma | 9 (11%) |
| Large cell carcinoma | 3 (4%) |
| Sarcomatoid carcinoma | 2 (2%) |
| Adenosquamous carcinoma | 3 (4%) |
| Tumor site sampling | |
| Primary | 60 (75%) |
| Metastatic | 20 (25%) |
| Median tumor size (range) cm | 2.5 (1–16) |
| pTNM stage | |
| IIIA | 33 (41%) |
| IIIB | 14 (18%) |
| IV | 33 (41%) |
| Differentiation grade | |
| Well | 17 (21%) |
| Moderate | 19 (11%) |
| Poor | 54 (68%) |
Abbreviations: TNM = tumor node metastasis.